Revolution Medicines, Inc. <RVMD.O>: Truist Securities raises target price to $231 from $210
RVMD•Related News
Coya Therapeutics posts investor presentation on Treg-directed combination therapy for neurodegenerative diseases
COYA•
Definitive Healthcare <DH.O>: Morgan Stanley cuts target price to $1.50 from $2.50
DH•
UK MHRA expands Rhythm’s IMCIVREE authorization to treat acquired hypothalamic obesity
RYTM•
Astrotech unit Lunar Power and Light plans commercial lunar electric utility network
ASTC•
Butterfly Network director Erica Schwartz steps down after CDC director confirmation
BFLY•